July 10, 2020 / 6:28 PM / a month ago

BRIEF-Citius Pharmaceuticals says Received Written Notice From Nasdaq That Co Had Regained Compliance With Rule 5550(A)(2)

July 10 (Reuters) - Citius Pharmaceuticals Inc:

* CITIUS PHARMACEUTICALS - RECEIVED WRITTEN NOTICE FROM NASDAQ THAT CO HAD REGAINED COMPLIANCE WITH RULE 5550(A)(2) Source text - bit.ly/3ef4JrB Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below